Edaravone
PubChem CID: 4021
Connections displayed (default: 10).
Loading graph...
| Compound Synonyms | edaravone, 89-25-8, 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE, Radicut, Norphenazone, 1-Phenyl-3-methyl-5-pyrazolone, Developer Z, MCI-186, Methylphenylpyrazolone, C.I. Developer 1, Norantipyrine, Phenyl methyl pyrazolone, Phenylmethylpyrazolone, Radicava, 3-Methyl-1-phenyl-5-pyrazolone, 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one, 3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one, 1-Phenyl-3-methyl-5-oxo-2-pyrazoline, CI Developer 1, 1-Phenyl-3-methylpyrazolone, 3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-, 1-Phenyl-3-methylpyrazolone-5, 2-Pyrazolin-5-one, 3-methyl-1-phenyl-, 3-Methyl-1-phenylpyrazol-5-one, 5-methyl-2-phenyl-4H-pyrazol-3-one, Colorex pmp, Jarocol pmp, 3-Methyl-1-phenyl-2-pyrazoline-5-one, NCI-C03952, 5-Pyrazolone, 3-methyl-1-phenyl-, 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one, Edaravone (MCI-186), NSC-2629, CCRIS 512, edaravona, NSC-26139, 1-Fenyl-3-methyl-2-pyrazolin-5-on, CHEBI:31530, HSDB 4102, UNII-S798V6YJRP, EINECS 201-891-0, S798V6YJRP, MFCD00003138, BRN 0609575, DTXSID9021130, AI3-03557, 3-methyl-1-phenyl-4,5-dihydro-1H-pyrazol-5-one, MLS000069602, 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE (MCI-186), DTXCID201130, EC 201-891-0, 1-Phenyl-3-methyl-2-pyrazolin-5-one, NCGC00164015-01, SMR000059020, EDARAVONE (MART.), EDARAVONE [MART.], Edaravone [INN], Monopyrazolone, WLN: T5NMV DHJ BR& E1, CAS-89-25-8, Radicut (TN), PHENAZONE IMPURITY A (EP IMPURITY), PHENAZONE IMPURITY A [EP IMPURITY], 3H-Pyrazol-3-one,4-dihydro-5-methyl-2-phenyl-, SR-01000000135, 1-Fenyl-3-methyl-2-pyrazolin-5-on [Czech], edaravonum, 3-?Methyl-?1-?phenyl-?2-?pyrazolin-?5-?one(Edaravone), MCI186, (Edaravone), 1 Phenyl 3 methyl 5 pyrazolone, Radicava (TN), (MCI-186), Edaravone (Standard), 3 Methyl 1 phenyl 2 pyrazolin 5 one, RADICAVA ORS, CDS1_000986, Spectrum_000267, Tocris-0786, EDARAVONE [JAN], MCI-186, Edaravone, Edaravone [USAN:INN], EDARAVONE [HSDB], EDARAVONE [USAN], Maybridge1_005738, Opera_ID_1057, Spectrum2_001574, Spectrum3_000971, Spectrum4_001091, Spectrum5_001217, NORPHENAZONE [MI], M0687, EDARAVONE [WHO-DD], N-DESMETHYLANTIPYRINE, SCHEMBL4704, BSPBio_001235, BSPBio_002601, KBioGR_000575, KBioGR_001502, KBioSS_000575, KBioSS_000747, AE-641/00371017, MLS001146878, MLS002415675, MLS006011753, DivK1c_001018, DivK1c_002026, SPECTRUM1503635, SPBio_001508, CHEMBL290916, 1-pheny-3-methyl-5-pyrazolone, Edaravone (USAN/JP17/INN), EDARAVONE [ORANGE BOOK], BCBcMAP01_000127, GTPL11994, HMS503K17, HMS557M18, HY-B0099R, KBio1_001018, KBio2_000575, KBio2_000747, KBio2_003143, KBio2_003315, KBio2_005711, KBio2_005883, KBio3_001029, KBio3_001030, KBio3_001821, N07XX14, NSC2629, NINDS_001018, 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one (Edaravone), BCPP000246, Bio1_000438, Bio1_000927, Bio1_001416, Bio2_000448, Bio2_000928, HMS1362M17, HMS1792M17, HMS1990M17, HMS2234M19, HMS3266F04, HMS3403M17, HMS3411L05, HMS3654L15, HMS3675L05, HMS3884A11, Pharmakon1600-01503635, BCP26336, DZB76567, HY-B0099, NSC26139, Tox21_112077, Tox21_201747, Tox21_302819, BDBM50200541, CCG-39352, MSK000657, NSC758622, s1326, STK201315, 1-Phenyl-3-methyl-2-pyrazolin-5-on, AKOS000313817, Tox21_112077_1, AC-4745, BCP9000635, CS-1832, DB12243, FE22642, NSC-758622, SB19128, IDI1_001018, IDI1_002203, NCGC00018218-01, NCGC00018218-02, NCGC00018218-03, NCGC00018218-04, NCGC00018218-05, NCGC00018218-06, NCGC00018218-07, NCGC00018218-08, NCGC00018218-10, NCGC00018218-17, NCGC00022665-02, NCGC00022665-04, NCGC00022665-05, NCGC00022665-06, NCGC00256515-01, NCGC00259296-01, SBI-0051836.P002, 1ST000657, DB-002517, NS00002708, SW148216-2, 5-methyl-2-phenyl-2,4-dihydro-3-pyrazolone, EN300-16234, 3-Methyl-1-phenyl-2-pyrazoline-5-one, 99%, 3-METHYL-1-PHENYL-2H-PYRAZOLIN-5-ONE, 4E-901, 5-methyl-2-phenyl-2,4-dihydro-pyrazol-3-one, D01552, D86209, 1-PHENYL-3-METHYL-DELTA3-PYRAZOL-5-ONE, 3-?Methyl-?1-?phenyl-?2-?pyrazolin-?5-?one, 3-PYRAZOLIN-5-ONE, 3-METHYL-1-PHENYL-, AB00375776_14, AB00375776_15, 2 4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one, 2,4-dihydro-2-phenyl-5-methyl-3H-pyrazol-3-one, Q335099, SR-01000000135-2, SR-01000000135-3, SR-01000000135-5, 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one #, BRD-K35458079-001-04-2, BRD-K35458079-001-12-5, BRD-K35458079-001-23-2, BRD-K35458079-001-27-3, BRD-K35458079-001-28-1, BRD-K35458079-001-29-9, BRD-K35458079-001-31-5, BRD-K35458079-001-33-1, Z50145861, F0391-0021, 3-Methyl-1-phenyl-2-pyrazoline-5-one, SAJ special grade, 3-Methyl-1-phenyl-2-pyrazoline-5-one, purum, >=98.0% (NT), Phenazone impurity A, European Pharmacopoeia (EP) Reference Standard, InChI=1/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H, 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one, 1-Phenyl-3-methyl-1H-4,5-dihydropyrazol-5-one, Methylphenylpyrazolone |
|---|---|
| Topological Polar Surface Area | 32.7 |
| Hydrogen Bond Donor Count | 0.0 |
| Heavy Atom Count | 13.0 |
| Isotope Atom Count | 0.0 |
| Molecular Complexity | 241.0 |
| Database Name | cmaup_ingredients;pubchem |
| Defined Atom Stereocenter Count | 0.0 |
| Iupac Name | 5-methyl-2-phenyl-4H-pyrazol-3-one |
| Prediction Hob | 1.0 |
| Xlogp | 1.3 |
| Molecular Formula | C10H10N2O |
| Prediction Swissadme | 0.0 |
| Inchi Key | QELUYTUMUWHWMC-UHFFFAOYSA-N |
| Fcsp3 | 0.2 |
| Logs | -1.798 |
| Rotatable Bond Count | 1.0 |
| Logd | 1.089 |
| Compound Name | Edaravone |
| Prediction Hob Swissadme | 0.0 |
| Exact Mass | 174.079 |
| Formal Charge | 0.0 |
| Monoisotopic Mass | 174.079 |
| Hydrogen Bond Acceptor Count | 2.0 |
| Molecular Weight | 174.2 |
| Covalent Unit Count | 1.0 |
| Total Atom Stereocenter Count | 0.0 |
| Total Bond Stereocenter Count | 0.0 |
| Esol | -1.995697061538461 |
| Inchi | InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3 |
| Smiles | CC1=NN(C(=O)C1)C2=CC=CC=C2 |
| Nring | 2.0 |
| Defined Bond Stereocenter Count | 0.0 |
- 1. Outgoing r'ship
FOUND_INto/from Sauromatum Giganteum (Plant) Rel Props:Source_db:cmaup_ingredients